INM: InMed Pharmaceuticals Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
11 open-market buys totaling $86K and 0 sales totaling - in the last 180 days.
Insider buys
| Score | Ticker | Company | Insider | Role | Trade date | Value | Holding + | Cluster |
|---|---|---|---|---|---|---|---|---|
| 8 | INM | InMed Pharmaceuticals Inc. | Adar1 Capital Management, Llc / Schneeberger Daniel | 10% Owner | 2026-10-19 | $1K | 0% | |
| 8 | INM | InMed Pharmaceuticals Inc. | Adar1 Capital Management, Llc / Schneeberger Daniel | 10% Owner | 2026-10-16 | $1 | 0% | |
| 8 | INM | InMed Pharmaceuticals Inc. | Adar1 Capital Management, Llc / Schneeberger Daniel | 10% Owner | 2026-10-15 | $1K | 0% | |
| 17 | INM | InMed Pharmaceuticals Inc. | Adar1 Capital Management, Llc / Schneeberger Daniel | 10% Owner | 2026-10-14 | $11K | 1% | |
| 8 | INM | InMed Pharmaceuticals Inc. | Adar1 Capital Management, Llc / Schneeberger Daniel | 10% Owner | 2026-10-13 | $750 | 0% | |
| 9 | INM | InMed Pharmaceuticals Inc. | Adar1 Capital Management, Llc / Schneeberger Daniel | 10% Owner | 2026-10-08 | $3K | 0% | |
| 9 | INM | InMed Pharmaceuticals Inc. | Adar1 Capital Management, Llc / Schneeberger Daniel | 10% Owner | 2026-10-07 | $4K | 0% | |
| 10 | INM | InMed Pharmaceuticals Inc. | Adar1 Capital Management, Llc / Schneeberger Daniel | 10% Owner | 2026-10-06 | $7K | 1% | |
| 19 | INM | InMed Pharmaceuticals Inc. | Adar1 Capital Management, Llc / Schneeberger Daniel | 10% Owner | 2026-10-05 | $24K | 2% | |
| 17 | INM | InMed Pharmaceuticals Inc. | Adar1 Capital Management, Llc / Schneeberger Daniel | 10% Owner | 2026-10-02 | $11K | 1% | |
| 19 | INM | InMed Pharmaceuticals Inc. | Adar1 Capital Management, Llc / Schneeberger Daniel | 10% Owner | 2026-10-01 | $22K | 2% |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.